Ginsenoside Rd attenuates blood-brain barrier damage by suppressing proteasome-mediated signaling after transient forebrain ischemia
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Neuroscience
Reference27 articles.
1. Central noradrenergic agonists in the treatment of ischemic stroke-an overview.;Sternberg;Transl Stroke Res,2019
2. Fluoxetine inhibits transient global ischemia-induced hippocampal neuronal death and memory impairment by preventing blood-brain barrier disruption.;Lee;Neuropharmacology,2014
3. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.;Liang;Stroke,2015
4. Blood-brain barrier protection as a therapeutic strategy for acute ischemic stroke.;Sifat;AAPS J,2017
5. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events.;Noble;J Neurosci,2002
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Panax notoginseng: panoramagram of phytochemical and pharmacological properties, biosynthesis, and regulation and production of ginsenosides;Horticulture Research;2024-07-02
2. Ginsenoside Rd enhances blood-brain barrier integrity after cerebral ischemia/reperfusion by alleviating endothelial cells ferroptosis via activation of NRG1/ErbB4-mediated PI3K/Akt/mTOR signaling pathway;Neuropharmacology;2024-06
3. Conversion by thermostable β-glucosidase Tpebgl3 improves the anti-tumor activity of Panax notoginseng saponins against breast cancer;Food Bioscience;2023-08
4. Exploring the Potential Therapeutic Approach Using Ginsenosides for the Management of Neurodegenerative Disorders;Molecular Biotechnology;2023-06-18
5. Secondary Metabolites of Oplopanax elatus: Possibilities for Standardization of a Multiphytoadaptogen for Preventive Oncology;Pharmaceutical Chemistry Journal;2023-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3